XML 53 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment and Geographic Information
 9 Months Ended
Sep. 30, 2015
Segment and Geographic Information [Abstract]  
Segment and Geographic Information

10. SEGMENT AND GEOGRAPHIC INFORMATION

The Company evaluates reporting segments in accordance with FASB ASC 280, “Segment Reporting”. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. These devices are developed and marketed to a broad base of medical centers in the United States and internationally. Management considers all such sales to be part of a single reportable segment. Revenue attributed to geographic areas is based on the location of the customers to whom products are sold.

Revenue by geographic area was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2015

 

2014

 

2015

 

2014

United States

 

$
24,665 

 

$
20,060 

 

$
73,332 

 

$
58,106 

Europe

 

 
3,972 

 

 
4,576 

 

 
12,510 

 

 
13,183 

Asia

 

 
2,609 

 

 
1,870 

 

 
7,447 

 

 
6,341 

Other international

 

 
177 

 

 
172 

 

 
603 

 

 
409 

Total international

 

 
6,758 

 

 
6,618 

 

 
20,560 

 

 
19,933 

Total revenue

 

$
31,423 

 

$
26,678 

 

$
93,892 

 

$
78,039 

 

Domestic revenue by product type was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2015

 

2014

 

2015

 

2014

Open-heart ablation

 

$
13,041 

 

$
11,265 

 

$
39,043 

 

$
32,498 

Minimally invasive ablation

 

 
5,011 

 

 
3,933 

 

 
14,415 

 

 
11,774 

AtriClip

 

 
5,927 

 

 
4,285 

 

 
17,716 

 

 
11,856 

Total ablation and AtriClip

 

 
23,979 

 

 
19,483 

 

 
71,174 

 

 
56,128 

Valve tools

 

 
686 

 

 
577 

 

 
2,158 

 

 
1,978 

Total domestic

 

$
24,665 

 

$
20,060 

 

$
73,332 

 

$
58,106 

 

International revenue by product type was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2015

 

2014

 

2015

 

2014

Open-heart ablation

 

$
4,092 

 

$
4,150 

 

$
12,396 

 

$
12,175 

Minimally invasive ablation

 

 
1,945 

 

 
1,804 

 

 
5,771 

 

 
5,773 

AtriClip

 

 
598 

 

 
543 

 

 
2,058 

 

 
1,390 

Total ablation and AtriClip

 

 
6,635 

 

 
6,497 

 

 
20,225 

 

 
19,338 

Valve tools

 

 
123 

 

 
121 

 

 
335 

 

 
595 

Total international

 

$
6,758 

 

$
6,618 

 

$
20,560 

 

$
19,933 

 

The majority of the Company’s long-lived assets are located in the United States.